| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113883.3.464.1003.110.12.1043 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1043 |
| version | 20170504 |
| status | active |
| publisher | NCQA PHEMUR |
| name | HaemophilusInfluenzaeTypeBHibVaccineAdministered |
| title | Haemophilus Influenzae Type B (Hib) Vaccine Administered |
| date | 2022-03-03T18:46:01-05:00 |
| experimental | false |
| Usages | (none) |
This value set contains 27 concepts
| Code | System | Display |
| 127787002 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 16292241000119109 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure) |
| 170343007 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170344001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170345000 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170346004 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 310306005 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310307001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310308006 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312869001 | http://snomed.info/sct | Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312870000 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 414001002 | http://snomed.info/sct | Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 414259000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415507003 | http://snomed.info/sct | Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415712004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 770608009 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770616000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770617009 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770618004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786846001 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 787436003 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure) |
| 90644 | http://www.ama-assn.org/go/cpt | Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use |
| 90647 | http://www.ama-assn.org/go/cpt | Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use |
| 90648 | http://www.ama-assn.org/go/cpt | Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use |
| 90697 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use |
| 90698 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use |
| 90748 | http://www.ama-assn.org/go/cpt | Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use |
Produced 08 Sep 2023